In this opinion column from Forbes.com, readers are offered a health policy assessment of Medicare Advantage from Contributor John C. Goodman.
Wild Blue’s Ken Janda notes that while Mr. Goodman doesn’t fully endorse the solution of Medicare Advantage for All, he does provide some interesting thinking around the parameters for solving the question of how do we cover all Americans with access to care in ways that are affordable and reasonable?
ACA (3)
Access (9)
Children (1)
Health Care (8)
Healthcare.gov (3)
health care financing (14)
Health Equity (3)
health insurance (13)
health system (3)
Insurance costs (1)
Marketplace (5)
Medicaid (5)
Medicare Advantage (4)
medication (1)
pharmacy costs (1)
PHE (1)
public health (1)
state (1)
Texas (7)
Uninsured (5)
Value Based Care (2)
